Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

171.39
Delayed Data
As of Aug 16
 +1.35 / +0.79%
Today’s Change
133.64
Today|||52-Week Range
184.21
+17.22%
Year-to-Date
AMGN Regular Dividend: AMGN began trading ex-dividend on 08/15/17. A $1.15 dividend will be paid to shareholders of record as of 08/17/17.

Today’s Trading

Previous close170.04
Today’s open170.26
Day’s range170.14 - 172.64
Volume1,618,756
Average volume (3 months)3,106,914
Market cap$124.1B
Dividend yield2.68%
Data as of 08/16/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+7.89%
Earnings growth (next 5 years)+4.06%
Revenue growth (last year)+6.31%
P/E ratio15.6
Price/Sales4.86
Price/Book4.20

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.23+0.31%
BIIBBiogen+6.16+2.14%
ILMNIllumina Inc+0.23+0.12%
KITEKite Pharma Inc+1.29+1.02%
Data as of 08/16/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$3.11
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts